1 the applicant bayer bioscience nv (bayer) claims that the respondent deltapine australia pty ltd (deltapine) has infringed bayer's australian patent no 89401499 (the patent) entitled "prevention of bt resistance development".
associate: dated: 10 february 2006 counsel for the applicant: a j ryan solicitors for the applicant: davies collison cave counsel for the respondent: s g b burley solicitors for the respondent: mallesons stephen jaques date of hearing: 1 february 2006 date of judgment: 10 february 2006 austlii: copyright policy | disclaimers | privacy policy | feedback url: http://www.austlii.edu.au/au/cases/cth/fca/2006/68.html
deltapine denies infringement and has cross-claimed alleging invalidity.